PA

Pawan Arora

Active Director Director DIN 09440187
DIN 09440187 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Pawan Arora

Data last updated:

Pawan Arora is a Director at Next Era Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Next Era Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (FY 2025).

DIN 09440187
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2021
Oldest Company Age 4 yrs
Largest company Next Era Pharmaceuticals Private Limited · ₹1.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20212021₹1.03 Cr (FY 2025)Active

Board colleagues of Pawan Arora

NameDINCompanyDesignation
Dharmik Arora09440188Next Era Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Next Era Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Arora

Pawan Arora currently holds 1 directorship: Next Era Pharmaceuticals Private Limited (Director, since 17 Dec 2021, revenue ₹1.03 Cr (FY 2025)).

Pawan Arora was first appointed on 17 Dec 2021 as Director at Next Era Pharmaceuticals Private Limited.

The current boards of Pawan Arora's companies include Dharmik Arora (Next Era Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available